The Growing AI Conundrum: Fake Reviews Edition
TINA.org supports consolidated FTC efforts to attack burgeoning issue.
Heermann et al. v. Alchemee, LLC et al.
24-cv-7550, W.D. Mo.
(March 2024)
Howard et al. v. Alchemee, LLC and Taro Pharmaceutical USA, Inc.
24-cv-1834, C.D. Cal.
(March 2024)
Judt et al. v. Alchemee, LLC and Taro Pharmaceuticals U.S.A., Inc.
24-cv-2718, S.D.N.Y.
(April 2024)
O’Dea et al. v. Alchemee, LLC and Taro Pharmaceuticals U.S.A., Inc.
24-cv-2755, N.D. Ill.
(April 2024)
Ramos et al. v. Alchemee, LLC
24-cv-2230, N.D. Cal.
(March 2024)
Teron et al. v. Alchemee, LLC and Taro Pharmaceuticals U.S.A., Inc.
24-cv-7538, N.D. Cal.
(March 2024)
Proactiv
Misleadingly representing that products were safe when they contained, or were at risk of containing, the carcinogen benzene
Heermann case: Pending
Howard cases: Dismissed
Judt case: Voluntarily dismissed When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled.
O’Dea case: Pending
Ramos case: Pending
Teron case: Pending
TINA.org supports consolidated FTC efforts to attack burgeoning issue.
In the new N°5 film, the story of two lovers’ missed connections, where the road to get there is just as important as the rendez-vous itself.
Supplement company stumbles over discount offer.
Danielle Friedman, The New York Times
Is this finally the candidate we all can trust?